ARCHIVES

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Fountain Hearings Turn Up Some Responsible Criticism, some Not, Much Support for Program

June 24, 1977

Funding Opportunities.

March 22, 2002

Gallo Publishes Study to Resolve controversy Over HIV Discovery

March 15, 1991

News Analysis: The Political Economy of Importation to Alleviate Cancer Drug Shortages

March 2, 2012

Lenalidomide Found Effective For Lymphoma In Phase II Trial

December 26, 2008

Senate Subcommittee Votes $970 Million for NCI In FY 1980; Magnuson Cancer Support Holds Firm

June 23, 1978